The Aptus Therapeutics-backed neurodegenerative disorder drug developer has filed for an $80.5m initial public offering on Nasdaq after raising roughly $30m in VC funding.

The Lund University spinout, which is working on diagnostics technology for applications in oncology, will use the proceeds to pursue a recruitment drive.

The mobile banking platform has closed a round co-led by Tencent and Allianz X, boosting its total funding to $215m as it prepares to enter the UK and US.

The electric bicycle drive manufacturer has been backed by Unternehmertum Venture Capital Partners.

Stanford-StartX Fund-backed TwoXar has added $10m in funding to its coffers thanks to SoftBank Ventures, Andreessen Horowitz and OS Fund.

The spinout, which has developed a portable real-time DNA and RNA sequencer, has attracted $140m in funding from investors including GIC, China Construction Bank and Hostplus.

The cloud software provider took its overall financing to at least $67m in a Dell-backed round and will spend the proceeds on growth, product development, sales and marketing.

GV and Walden International co-led the Stanford spinout's series A round, which was announced as it emerged out of stealth.

Proceeds from the Singel Innov8-led series A round will support development and production of Airspace Systems' drone interception system.

GV and Walden International co-led the computing technology developer's series A round, which was announced when it came out of stealth.